Remove topic
article thumbnail

Behind the new topical treatment set to disrupt the psoriasis market

PharmaVoice

Phil Brown, Dermavant’s chief medical officer, discusses VTAMA — the first topical cream approved for psoriasis in 25 years.

246
246
article thumbnail

Topical Corticosteroids

RX Note

Introduction Topical corticosteroids have a major role in the management of many skin diseases. The potency classification of topical corticosteroid above is extracted from Australian Medicines Handbook , which potency estimate is based on vasoconstrictive ability, inhibition and potential for causing adverse effects.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Make pharmacy an election topic, urges RPS

The Pharmacist

If elected, these MPs would campaign […] The post Make pharmacy an election topic, urges RPS appeared first on The Pharmacist. It has developed a pledge, dubbed a ‘Pharmacy Manifesto’, asking MPs to sign a ‘prescription for the nation’s health’.

94
article thumbnail

Topical Metformin Using a Permeation Enhancing Base and Diabetes

Welltopia Pharmacy

Topical Metformin: A New Era in Diabetes Care Understanding Diabetes: Types and Prevalence Diabetes, a chronic condition affecting millions worldwide,

Diabetes 100
article thumbnail

Lupin US FDA approval for Fluocinolone Acetonide Topical Oil

Express Pharma

Fluocinolone Acetonide Topical Oil (RLD Derma-Smoothe/FS) had estimated annual sales of $9 million in the US. Fluocinolone Acetonide Topical Oil (RLD Derma-Smoothe/FS) had estimated annual sales of $9 million in the US. The post Lupin US FDA approval for Fluocinolone Acetonide Topical Oil appeared first on Express Pharma.

77
article thumbnail

Topical Preparations

RX Note

It has been estimated that for topical products such as creams and gels, typically only between 1% and 3% of the applied dose is bioavailable. NOTE: Topical treatments used for local effects have a decreased incidence of systemic side effects and generally provide faster relief. Factors affecting formulation type of topical therapy.

article thumbnail

Krystal Biotech receives FDA approval for DEB topical gene therapy

Pharmaceutical Technology

Krystal Biotech has received approval from the US Food and Drug Administration for topical gene therapy VYJUVEK to treat dystrophic epidermolysis bullosa (DEB) in adults and in children aged six months and above. Topic sponsors are not involved in the creation of editorial content.

105
105